Studies of adult BALB/c mice given total lymphoid irradiation (TLI; 3,400 rad) 1 have shown that both heterologous proteins and allogeneic bone marrow (BM) cells injected into irradiated mice evoke a state of tolerance rather than immunity (1). The ease of induction of tolerance to protein antigens appears to be related to the development of a population of T cells that can nonspecifically suppress the in vivo adoptive antibody response to the dinitrophenyl (DNP) hapten coupled to heterologous proteins such as bovine serum albumin (BSA) and bovine gammaglobulin (2). Similarly, the initial lack of responsiveness to allogeneic BM cells in TLI-treated mice is related to the presence of T cells that can nonspecifically suppress the mixed leukocyte reaction (MLR) in vitro and graft-vs.-host disease in vivo (3).
irradiation. Tetracycline (0.5/.tg/ml) was added to the drinking water during TLI and for 1 wk after completion of irradiation.
Radiotherapy. TLI (3,400 rad) or WBI (500-550 tad) was administered to 4-6-too-old BALB/c mice as described previously (3) . TLI was given to ports including the cervical, axillary, mediastinal, para-aortic, and inguinal lymph nodes, as well as to the spleen and thymus (3) . 17 fractions of 200 rad each were administered 5 d/wk during a period of 3-4 wk.
Preparation of Cells.
Spleen cell suspensions were prepared by gently pressing spleen fragments through a nylon fiber mesh (Tetko, Inc., Elmsford, N. Y.) into cold modified minimal essential medium (Iso-MEM; Grand Island Biological Co., Grand Island, N. Y.), as described before (3).
Thymectomy. Thymectomy was performed on 2-3-mo-old BALB/c male mice using ether or sodium pentobarbital for anesthesia. The incision of the neck was closed with surgical clips. At 7-8 mo of age, half the mice were given TLI (total dose 3,400 rad), and the remainder served as thymectomized, nonirradiated controls. Each animal was carefully checked for the presence of residual thymic tissue in the mediastinum at the time of killing, and individual mice were eliminated from the study if thymectomy was incomplete.
Preparation of Antigens. BSA (Cohn fraction V; Sigma Chemical Co., St. Louis, Mo.) was dissolved in saline at a final concentration of 20 mg/ml before mixing with complete Freund's adjuvant (CFA). BSA was dinitrophenylated using a modification of the procedure of Eisen (4) . Readings of the absorbence of the conjugated protein at 280 and 360 nm yielded a value of 8.5 mg protein/ml and 10 DNP groups per molecule of BSA.
Immuhization Piocedures. Donors of carrier (BSA)-primed T cells were immunized 8-12 wk before cell transfer with 500 ~g BSA, by an intraperitoneal injection of an emulsion of equal volumes of BSA in saline and CFA (Difco Laboratories, Detroit, Mich). Donors of hapten (DNP)-primed B cells were immunized with 500 p.g DNP-BSA in CFA as described above.
Antisera. Anti-Thy-l. Preparation of Purified T Cells. Cell suspensions of mesenteric lymph nodes taken from BSAprimed donors -8 wk after immunization were applied to columns of nylon wool (LP-1 LeukoPak filter; Fenwal Laboratories, Morton Grove, Ill.), as described by Julius et al. (6) . Nylon Wool was washed before use by boiling in distilled water, and dried in an oven. Approximately 3.6 g of nylon wool was gently picked free of clumps, and the wool was packed to the 50-ml mark in 60-ml syringes. The column was wet with Iso-MEM containing 5% heat-inactivated fetal calf serum (Grand Island Biological Co.), and allowed to equilibrate for 1 h at 37°C. Approximately 65 X 106 cells in 1.5 ml were loaded in each column, and the columns were reincubated at 37°C for 45 rain. Nonadherent cells were removed from the column with an excess (120 ml) of medium by gently flushing the column. Direct cytotoxicity of the effluent cells using the anti-Thy-l.2 alloantiserum and complement resulted in lysis of 85% or more of the nonadherent population.
Preparation ofDNP-primed B Cells. T cells were depleted from spleen cell suspensions prepared from DNP-BSA-primed donors by a two-stage in vitro cytotoxicity procedure. Cells at 10 X 106/ml were incubated with anti-Thy-l.2 serum (final dilution, 1:5 in Iso-MEM) for 45 min at 4°C. The suspension was spun down and the cells were resuspended in an equal volume of agarose-absorbed rabbit serum, diluted 1:12 (complement source). The reaction mixture was incubated for 45 min at 37°C. The remaining cells were spun down, washed twice, and resuspended in Iso-MEM before injection into adoptive hosts. Approximately 40-55% of the spleen cells were lysed by this procedure.
Treatment of Cells from TLl-treated Donors with Antisera and Complement. Spleen cell suspensions
were prepared from mice after the completion of TLI. Cells (10 X 106/ml) were incubated for 45 min at 4°C with anti-Thy-1.2 or anti-TL antiserum (final dilution of anti-Thy-1.2 antiserum, 1:5; final dilution of anti-TL antiserum, 1:15). Cells were collected by centrifugation, resuspended in an equo.! volume of a 1:12 dilution of agarose-absorbed rabbit complement, and incubated for 45 min at 37°C. Residual spleen cells were spun down and resuspended in Iso-MEM for injection, or re'suspended in complete medium for assay in the MLR. In the case of cells to be used in the MLR assay, complement treatment was repeated twice to ensure complete lysis of all target cells.
Cell Transfer System. 3-4-too-old BALB/c mice were given 500 rad WBI. 1 d later, they were injected intravenously with limiting numbers (5 × 106) of BSA-primed, nylon wool-purified T cells and an excess (5 × 106) of DNP-primed, anti-Thy-l.2-treated B cells. The B cells were determined to be in excess in a series of experiments in which animals reconstituted with 10 × 106 T cells and graded numbers of purified B cells showed identical, maximal levels of the anti-DNP antibody response with cell doses between 5 × 106 and 25 × 106 B cells. The dose of 5 X 106 BSA-primed T cells was determined to be on the linear portion of the dose response curve in a similar experiment (data not shown). Adoptive hosts were challenged with 200/~g DNP-BSA in saline intraperitoneally 1 d after cell transfer. The animals had a combination of antibiotics consisting of 10 mg/ml polymyxin B (Sigma Chemical Co.) and 50 mg/ml neomycin sulfate (Pharma-Tek, Inc., Huntington, N. Y.) added to their drinking water from 1 wk before irradiation to 2 wk after cell transfer. The recipients were housed in conventional animal rooms with food and water ad libitum.
Antibody Titration. Mice were bled from the retro-orbital plexus at weekly intervals after antigenic challenge. The serum was separated by centrifugation and stored at -20°C. The anti-DNP content of the sera was calculated in terms of antigen-binding capacity (ABC), using [3H]-DNP-lysine (New England Nuclear Corp., Boston, Mass.) as the ligand in a modification of the Farr assay (7). Each serum sample was assayed in triplicate. The mean ABC determination from groups of four animals was calculated as the mean of individual serum ABC within that group.
Assay for Suppression of the Adoptive Antibody Response.
In all experiments designed to determine the suppressor cell activity of spleen cells from TLI-treated donors, adoptive hosts received 5 × 10 ~ DNP-primed B cells, 5 × 106 BSA-primed T cells, and 25 × 10 ~ cells from donors given TLI. Recipients were challenged with DNP-BSA, and serum antibodies were measured as described above.
MLR.
Responder (1 × 10 ~) and stimulator (1 × 106) cells were cultured in a final volume of 0.2 ml/well, using flat-bottomed microculture plates (3596; Costar, Data Packaging, Cambridge, Mass.). The cells were incubated in RPMI-1640 medium supplemented with 10% human AB serum (batch A481917), 2 mM glutamine, 100 U/ml penicillin, 100 /~g/ml streptomycin, and 10 mM Hepes buffer (all from Grand Island Biological Co.). Cultures were incubated for 96 h at 37°C in anatmosphere of 5% CO2 in air. Stimulator cells were treated with 3,400 rad from a 137Cesource (Mark 1 model 25 irradiator, J. L. Shepherd and Associates, Glendale, Calif.) just before culture.
DNA synthesis was assayed by the addition of 1.0 ~Ci tritiated thymidine ([3H]TdR, sp ac 6.7 Ci/mM; New England Nuclear Corp.) to each culture during the final 18 h of the incubation period. Cultures were harvested onto glass fiber filter paper (Whatman, Inc., Clifton, N. J.) by means of an automated sample harvester (Bio-Plastics, Redwood City, Calif.). The filters were washed with saline, dried, and placed into a scintillation cocktail composed of spectrafluor (Amersham Corp., Arlington Heights, Ill.) and toluene. Isotope incorporation was measured in a liquid scintillation counter (Beckman Instruments, Inc., Fullerton, Calif.).
MLR-Suppressor Assay. Culture conditions were as described for the MLR except that 1 × 10 6 responder, stimulator, and putative suppressor cells were incubated in a final volume of 0.3 ml/well. Stimulator and putative suppressor cells were treated in vitro with 3,400 and 1,500 rad, respectively, before assay. Data shown for all MLR cultures are the mean cpm and the SE of triplicate cultures. The stimulation index was calculated as the ratio of cpm from cultures containing allogeneic responder and stimulator cells to cpm from cultures containing syngeneic responder and stimulator cells. The following formula was used to calculate suppression: percent suppression = 1 -cpm withcpmPUtatiVewith controlcellsSuppress°r cells × 100.
Results

Development of Suppressor Cells of the Adoptive Anti-DNP Response after TLL
25 × l0 G spleen cells from mice given either TLI or a single dose of WBI (550 rad) were transferred to adoptive hosts along with BSA-primed T ceils (5 × 106) and DNPprimed B cells (5 × 106). In both cases, putative suppressor cells were obtained -1 mo after irradiation. Recipient mice were challenged intraperitoneally with DNP-BSA in saline, and anti-DNP serum antibodies were determined. Table I shows that spleen cells from TLI-treated donors, but not from donors treated with sublethal WBI, suppressed the adoptive anti-DNP response on days 14 and 21 by 99 and 92% as compared with that observed with 25 × 106 cells from normal (nonirradiated) BALB/c mice. Suppression of the response was evident at all times measured up to 35 d after challenge (data not shown). In addition, the level of suppression in different experiments varied somewhat. The mean percent suppression from five experiments was 89% at day 14 and 86% at day 21 after challenge. The injection of 25 × 106 normal cells appeared to have no substantial effect on the magnitude of the response exhibited by primed T and B cells alone. The responses of adoptive hosts receiving 25 × 106 cells from normal or WBI-treated donors were similar (Table I) .
Persistence of Suppressor Cells of the Adoptive Anti-DNP Responses after TLI.
To determine the kinetics of suppressor cell activity after completion of TLI, spleen cells were obtained from mice at various times after radiotherapy. Cells obtained from mice at similar times after a single dose of WBI served as controls. As seen in Table II, (Table II) . Although cells taken from TLI-treated donors within 1 mo after irradiation appeared to show greater suppression than spleen cells taken at later times after TLI (~90% suppression vs. ~80% suppression, Table II) , variability in the level of suppression between similar experimental groups could account for these differences. the antiserum was used at a concentration known to be on the plateau portion of the dilution curve. Control responses were those of adoptive hosts receiving 25 × 106 untreated cells from WBI-treated animals or 25 × 106 cells from TLI-treated animals treated with normal mouse serum (NMS) and complement before transfer. Cells were obtained 1 mo after either TLI or WBI. Table III shows that both anti-Thy-l.2 and anti-TL treatment of spleen cells from TLI-treated donors markedly reduced their suppressive activity. In the case of treatment with the anti-TL serum, suppression was completely eliminated (Table III) . The same pattern was seen in four out of four experiments (data not shown). Spleen cells from TLI-treated mice that were treated with NMS and complement before transfer still exhibited potent suppressive activity (Table III) . These results suggest that the suppressor cells of the adoptive anti-DNP response are a population of T cells that bear the TL surface antigen.
Surface Markers of TLI-induced Suppressor Cells of the
Effect of Thymectomy on Anti-DNP Suppressor Cell Activity.
Our recent work .) shows that adult thymectomy before TLI will prevent the appearance of cells bearing the TL surface antigens (TL + cells) in the peripheral tissues of irradiated mice. It was therefore of interest to determine the effect of thymectomy on the generation of cells capable of suppressing the adoptive anti-DNP response. Adult BALB/c mice were thymectomized as described in Materials and Methods. 5-6 mo after surgery, one half of the thymectomized group was given TLI (total dose, 3,400 rad). The remainder of the mice served as thymectomized, nonirradiated control animals. Cell suspensions were prepared from spleens obtained from mice given a single dose of WBI, from nonirradiated, thymectomized mice, and from TLI-treated mice both with and without thymectomy before irradiation. Cells were obtained from all irradiated donors within 3 mo after completion of irradiation and transferred with primed T and B cells into adoptive hosts. As seen before, spleen cells from TLI-treated animals markedly reduced the anti-DNP response of adoptive hosts, as compared with cells from WBI-treated control mice (Table IV) . However, thymectomy of donor mice before administration of TLI completely eliminated the suppressor activity of the spleen cells (Table IV) . Spleen cells from thymectomized, nonirradiated mice did not suppress the adoptive anti-DNP response (Table IV) . and positive controls, respectively. All cells received 1,500 rad in vitro before addition to the MLR. As shown in Table V , treatment of the spleen cells from TLI-treated mice with anti-Thy-l.2 antibodies and complement substantially reduced their suppressive activity. However, treatment of the same cells with an anti-TL serum and complement was ineffective in removing suppressor cell activity. Suppression mediated by these cells remained equal to that of NMS-treated cells (Table V) . Thus, the MLR suppressor cells express the Thy-1 +, TL-surface antigen phenotype.
Surface Markers of TLI-induced Suppressor Cells of the MLR.
Effect of Adult Thymectomy on the Appearance of MLR Suppressor Cells after TLI.
The effect of adult thymectomy before TLI on the subsequent appearance of the MLR suppressor cells was also investigated. BALB/c mice were thymectomized as previously described, and 5-6 mo later, one half of the group of thymectomized animals received TLI (total dose, 3,400 rad). At various times after completion of TLI, spleen cells obtained from mice in both the nonirradiated, thymectomized group and the thymectomized group given TLI were assayed for suppressor cell activity in the MLR. Cells from normal (nonirradiated) BALB/c mice served as additional coculture control cells.
As shown in Table VI , cells obtained from thymectomized TLI-treated animals 7 d after completion of TLI markedly suppressed (73%) the MLR. In most cases, the addition of cells from either normal or adult thymectomized, nonirradiated mice did not affect the magnitude of the normal two-party MLR, although the addition of cells from thymectomized animals occasionally resulted in a slight reduction of the response as compared with the addition of cells from normal (untreated) mice (data not shown). In assessing suppressor activity, comparisons were made between cells from thymectomized, nonirradiated, and thymectomized, TLI-treated animals.
The pattern of persistence of the suppressor cell after TLI was also monitored in these experiments, using cells obtained from irradiated mice at various times after completion of TLI. Thymectomy before TLI appeared to have no effect on the previously demonstrated pattern of persistence of the suppressor cells (3). Suppressor activity gradually decreased with increasing time between irradiation and suppressor cell assay (Table VI) . By 55 d after TLI, no suppressor activity could be demonstrated using spleen cells from TLI-treated animals (Table VI) Although the suppressor cells of the MLR in TLI-treated mice were removed after incubation with anti-Thy-l.2 antibodies and complement (see also ref.
TABLE V
Effect of Treatment with Anti-TL Antibodies and Complement on Suppressor Cells of the MLR
3), these cells appear to differ from those that suppress the adoptive anti-DNP response. The activity of the MLR suppressors was neither eliminated by treatment with anti-TL serum and complement, nor by adult thymectomy before TLI. In addition, previous work has shown that these suppressor cells are detectable for only 30-40 d after completion of irradiation (3) . These studies indicate that at least two distinct suppressor T cell populations that differ both in their cell surface antigen phenotype and in their functional capabilities are present in the peripheral lymphoid tissues after TLI (Table  VII) .
Nonspecific Nonspecific suppressor cells of the MLR have also been reported previously in the spleens ofaduh animals. Folch and Waksman (11) described the presence of a weakly, glass-adherent, thymus-dependent suppressor cell of the MLR in the spleens of unimmunized adult rats. Removal of this cell population resulted in an increase in 13) . These cultured cells nonspecifically suppress the MLR and the in vitro induction of cell-mediated cytotoxicity (13) . The unexpected finding that two distinct suppressor T cell subpopulations appear to regulate different aspects of immune responsiveness in TLI-treated mice adds an additional level of complexity to the analysis of the cellular mechanisms that underlie the unusual effects of TLI on the immune system. The role of these suppressor cells in the induction of tolerance to heterologous proteins or transplantation antigens in TLItreated mice (2, 14) is not clear. It is possible that the TL + nonspecific suppressor cells differentiate into antigen-specific suppressor cells after interaction with heterologous proteins in solution. This'notion is consistent with the presence of antigen-specific suppressor T cells in the spleens of TLI-treated mice tolerized to BSA by the intraperitoneal injection of the protein in saIine (2) .
However, it is unlikely that the TL-nonspecific suppressors of the MLR differentiate into antigen-specific suppressors that mediate transplantation tolerance after stimulation with alloantigens. Our recent data suggest that the non-antigen-specific MLR suppressors facilitate tolerance induction in allogeneic BM chimeras by the preferential inhibition of the generation of cytolytic T cells from cytolytic T cell precursors. However, the nonspecific suppressors do not inhibit the generation of a new population of antigen-specific suppressor cells that appear to maintain tolerance in the chimeras (D. P. King and S. Strober, manuscript in preparation). Thus, the two subpopulations of suppressor cells in TLI-treated mice may not only act on different target cell populations, but may also function through different mechanisms of regulator-effector cell interactions. Summary BALB/c mice treated with total lymphoid irradiation (TLI) develop non-antigenspecific suppressor cells of the adoptive secondary antibody response and of the mixed leukocyte rea~ztion; Suppressors of the adoptive anti-DNP response were eliminated by incubation of spleen cells with anti-Thy-l.2 or anti-thymus-leukemia (TL) antiserum and complement before cell transfer. Thymectomy before TLI prevented the appearance of the latter suppressor cells. On the other hand, suppressors of the MLR were eliminated by incubation of spleen cells with anti-Thy-l.2 but not anti-TL antiserum and complement. Thymectomy before TLI did not prevent their subsequent development. Thus, two subpopulations of suppressor T cells that differ in the expression of the TL surface antigen, dependence on the presence of the thymus, and in regulatory functions develop after TLI. The TL +, thymus-dependent cell suppresses the adoptive antibody response, and the TL-, thymus-independent cell suppresses the MLR.
